SciTransfer
Organization

INNOSYSTEMS SYMVOULEUTIKES YPIRESIES KAI EFARMOGES PLIROFORIKIS YPSILIS TECHNOLOGIAS MONOPROSOPI IDIOTIKI KEFALAIOUCHIKI ETAIREIA

Greek AI and data analytics SME delivering decision-support tools for digital health monitoring and pandemic crisis management.

Technology SMEdigitalELSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€540K
Unique partners
50
What they do

Their core work

INNOSYSTEMS is a Greek IT consultancy and software firm specialising in applied artificial intelligence, big data analytics, and decision-support systems. Their documented work focuses on building intelligent platforms that turn complex, heterogeneous data into actionable intelligence — whether for monitoring cancer patients after treatment or predicting and managing large-scale public health crises. In ONCORELIEF they contributed AI and big data capabilities to a digital health platform supporting oncology follow-up care; in STAMINA they worked on machine learning, NLP, and predictive analytics for pandemic crisis decision support. Their practical niche is translating AI research into operational tools that support real-world decision-makers under high-stakes conditions.

Core expertise

What they specialise in

Artificial intelligence and machine learning for decision supportprimary
2 projects

AI and machine learning appear as core contributions in both ONCORELIEF (digital health monitoring) and STAMINA (pandemic crisis management), confirming this as their defining capability.

Big data analytics and predictive modellingprimary
2 projects

Big data analytics drove ONCORELIEF's patient monitoring layer, while STAMINA applied predictive analytics and early warning modelling to pandemic scenarios.

Natural language processing (NLP) for situational awarenesssecondary
1 project

NLP is listed as a STAMINA keyword, pointing to text-mining or information-extraction work in the context of crisis common operational pictures.

Digital health and patient wellbeing platformssecondary
1 project

ONCORELIEF (EUR 368,750 share) centred on digital tools enhancing cancer patient wellbeing and health-status tracking after treatment.

Crisis management and pandemic preparedness informaticsemerging
1 project

STAMINA specifically addressed pandemic prediction and management decision support, introducing crisis-domain keywords not present in their earlier project.

Evolution & trajectory

How they've shifted over time

Early focus
Digital health AI and big data
Recent focus
Pandemic crisis AI decision support

Both H2020 projects launched in 2020, so the timeline does not show a multi-year arc so much as a simultaneous pivot across two domains. Their first project (ONCORELIEF) anchored their identity in digital health — big data, AI, and patient wellbeing — while their second (STAMINA) immediately extended that AI/analytics core into security and crisis management, adding NLP, bioinformatics, diagnostics, and pandemic-specific concepts. The shift in keywords from "wellbeing" and "big data analytics" toward "common operational picture," "early warning," and "PCR/bioinformatics" suggests they actively sought to broaden their addressable market by applying the same AI toolbox to crisis-response contexts. If this trajectory continues, they are likely moving toward cross-domain AI platforms that serve both health systems and emergency management authorities.

INNOSYSTEMS appears to be expanding from digital health into public safety and crisis management, using AI and NLP as a portable toolkit — making them a candidate partner for any consortium needing intelligent data-fusion or early-warning components in health-security intersections.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European19 countries collaborated

INNOSYSTEMS has never led an H2020 project; they enter as specialist participants, contributing technical AI and analytics components to larger consortia rather than driving the overall project vision. Their two projects collectively involved 50 unique partners across 19 countries, which is unusually high for just two projects and indicates they joined large, multi-partner consortia rather than small focused teams. This suggests they are comfortable operating as one technical node among many and will slot into an established consortium structure without requiring a leadership mandate.

Despite only two projects, INNOSYSTEMS has built a notably wide network of 50 unique partners spanning 19 countries — a breadth that reflects participation in large EU consortia rather than repeat bilateral partnerships. Their collaborations appear geographically diverse across Europe with no single dominant country cluster visible from the available data.

Why partner with them

What sets them apart

INNOSYSTEMS occupies an uncommon intersection: an SME that applies AI, big data, and NLP simultaneously to both clinical health outcomes and emergency/pandemic crisis management — two domains that rarely share the same technology partner. For consortium builders, this cross-domain portability means a single organisation can cover the analytical intelligence layer across health, security, and public-administration workpackages. As a Greek SME they also add geographic diversity and can serve as a bridge to Southeastern European networks and institutions.

Notable projects

Highlights from their portfolio

  • ONCORELIEF
    Their largest project by funding (EUR 368,750 EC share), combining big data analytics and AI to support cancer patient monitoring and wellbeing after treatment — a high-impact digital health application with clear commercial transferability.
  • STAMINA
    Demonstrates their ability to pivot the same AI/NLP toolkit into pandemic preparedness and crisis decision support, including bioinformatics and diagnostics elements that significantly broaden their claimed expertise beyond pure IT consulting.
Cross-sector capabilities
healthsecuritysociety
Analysis note: Profile is based on only two projects, both beginning in the same year (2020), which limits meaningful longitudinal analysis. The "early vs recent" keyword split reflects two simultaneous projects rather than a true temporal evolution. The breadth of recent-period keywords (bioinformatics, PCR, diagnostics) may reflect consortium-level keywords rather than INNOSYSTEMS' direct contributions. Treat expertise claims outside core AI/analytics with caution until further project evidence is available.